News
July 15, 2011
CaRE Foundation is Partnering with AtriCure® for ABLATE AF Registry
The ABLATE AF Registry is an FDAapproved trial collecting data on the use of the AtriCure Bipolar System. This system uses radiofrequency ablation as a less invasive system to create many of the lesions previously accomplished using the “cut and sew” Maze technique. CLICK HERE TO READ MORE ABOUT THIS CLINICAL TRIAL.
CaRE Foundation is currently enrolling patients. For more information about ABLATE AF or to refer a patient, please contact Emmalee Nichols at 715.847.CARE or 715.847.2273.